drugset / Trial / NCT04183725
Clinical Study of Reduning Injection for the Treatment of Influenza in Children
Phase 4
Unknown
240 enrolled
China Academy of Chinese Medical Sciences
Anhui Provincial Children's Hospital · collabChildren's Hospital of Soochow University · collabHebei Maternity&Child Healthcare Hospital · collabQilu Children's Hospital of Shandong University · collabRenmin Hospital of Wuhan University · collabShaanxi Hospital of Traditional Chinese Medicine · collabThe First Affiliated Hospital of Hunan University of Traditional Chinese Medicine · collabThe Second Affiliated Hospital of Jiaxing University · collabTianjin 4th Centre Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy, safety of Reduning injection for the treatment of influenza in children.
Timeline
- Start
- 2019-12-01
- Primary completion
- 2021-06-01
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oseltamivir | Small molecule | 30 mg | — |
| Comparator | Oseltamivir | Small molecule | 45 mg | — |
| Comparator | Oseltamivir | Small molecule | 60 mg | — |
| Comparator | Oseltamivir | Small molecule | 75 mg | — |
| Subject | Reduning | Traditional medicine (herbal / TCM) | 0.5 unknown | Intravenous |
| Subject | Reduning | Traditional medicine (herbal / TCM) | 10 ml | Intravenous |
| Subject | Reduning | Traditional medicine (herbal / TCM) | 15 ml | Intravenous |
| Subject | Reduning | Traditional medicine (herbal / TCM) | 20 ml | Intravenous |
Indications
No indication recorded.